General MedicationsOPHTHALMICStandard
CEQUA
CYCLOSPORINE
Standard Dose
0.09%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CEQUA is listed in Drugs@FDA under application 210913 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CYCLOSPORINE Form and strength SOLUTION;OPHTHALMIC - 0.09% Sponsor SUN PHARM Submission history Latest submission status date: 2019-09-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview CEQUA is listed in Drugs@FDA under application 210913 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CYCLOSPORINE Form and strength SOLUTION;OPHTHALMIC - 0.09% Sponsor SUN PHARM Submission history Latest submission status date: 2019-09-20 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.